Evidence
Curr Med Imaging. 2024 Feb 7. doi: 10.2174/0115734056275504231126033905. Online ahead of print.
ABSTRACT
OBJECTIVES: To evaluate the diagnostic value of ultrasound-guided attenuation parameter (UGAP) in metabolic fatty liver disease (MAFLD) and to explore the correlation between the attenuation coefficient (AC) value of UGAP and commonly used clinical obesity indicators.
METHODS: A total of 121 subjects who had physical examinations from November 2021 to March 2022 were prospectively selected; the height, weight, and waist circumference (WC) of all subjects were collected, and conventional ultrasound and UGAP examinations for all subjects.
RESULTS: Under the standard of conventional ultrasound, among the 121 subjects, 53 had normal liver, 42 had mild fatty liver, 21 had moderate fatty liver, and 5 had severe fatty liver. The mean AC value of 121 patients was 0.66 ± 0.13 dB/cm/MHz. The best cut-off values for diagnosing mild, moderate, and severe fatty liver were 0.65dB/cm/MHz, 0.72dB/cm/MHz, and 0.83dB/cm/MHz, respectively. The area under the curve (AUC) values were 0.891, 0.929, and 0.914, respectively. When grouped by WC, there was a statistically significant difference in AC value between the normal group and the obese group (t=-4.675, P<0.001). Overall WC and within group WC were moderately correlated with the AC value of UGAP (P<0.001).
CONCLUSIONS: UGAP has a good diagnostic value in the quantitative evaluation of liver steatosis in MAFLD, and the change of WC can reflect the occurrence of liver steatosis to a certain extent.
PMID:38333977 | DOI:10.2174/0115734056275504231126033905
Add to Google Keep
Estimated reading time: 4 minute(s)
Latest: Psychiatryai.com #RAISR4D
Cool Evidence: Engaging Young People and Students in Real-World Evidence
Real-Time Evidence Search [Psychiatry]
AI Research [Andisearch.com]
The Diagnostic Value of Ultrasound-guided Attenuation Parameter (UGAP) in metabolic fatty liver disease
🌐 90 Days
VR Related Evidence Matrix
- Correlation of Grades of Non-alcoholic Fatty Liver on Ultrasound With Blood Parameters
- Nonalcoholic Fatty Liver Disease and Continuous Metabolic Syndrome in Adolescents with Overweight/Obesity
- Increased Risk of Colorectal Adenomas with Metabolic-Associated Fatty Liver Disease Components
- Correlation between neck circumference and hepatic steatosis determined by controlled attenuation parameter
- Ultrasonographic findings of metabolic dysfunction-associated fatty liver disease: A comparative study with non-alcoholic fatty liver disease and clinical characteristics
- Bronchiectasis Severity Index and FACED scores in patients with allergic bronchopulmonary aspergillosis complicating asthma: do they correlate with immunological severity or high-attenuation mucus?
- Feasibility and Safety of Percutaneous Puncture Guided by a 5G-Based Telerobotic Ultrasound System: An Experimental Study
- Liver and atherosclerotic risks of patients with cryptogenic steatotic liver disease
- Performance of ATT and UDFF in the diagnosis of non-alcoholic fatty liver: An animal experiment
- Metabolic-associated fatty liver disease: a selective review of pathogenesis, diagnostic approaches, and therapeutic strategies
- Targeting metabolic-associated fatty liver disease in diabetic kidney disease: A call to action
- The outcomes of nutritional therapy in patients with non-alcoholic fatty liver disease (NAFLD): Pitfalls in getting fit from fat
- Visceral and subcutaneous abdominal fat is associated with non-alcoholic fatty liver disease while augmenting Metabolic Syndrome's effect on non-alcoholic fatty liver disease: A cross-sectional study of NHANES 2017-2018
- Metabolic Derangement in Non-Alcoholic Fatty Liver Disease: Opportunities for Early Diagnostic and Prognostic Markers
- Mass spectrometry imaging-based metabolomics highlights spatial metabolic alterations in three types of liver injuries
- Muscle strength and non-alcoholic fatty liver disease/metabolic-associated fatty liver disease
- From metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease: Controversy and consensus
- Association between cardiometabolic index and controlled attenuation parameter in U.S. adults with NAFLD: findings from NHANES (2017-2020)
- Effect of Intermittent Fasting on Lipid Profile, Anthropometric and Hepatic Markers in Non-Alcoholic Fatty Liver Disease (NAFLD): A Systematic Review
- Development and Internal Validation of a Model for Predicting Overall Survival in Subjects with MAFLD: A Cohort Study
- Clinical Efficacy of Ultrasound-Guided Acupuncture in the Treatment of Chronic Subjective Dizziness
- MAFLD as part of systemic metabolic dysregulation
- MAFLD as part of systemic metabolic dysregulation
- Association of sex-specific body mass index and waist circumference trajectories with non-alcoholic fatty liver disease incidence based on growth mixture modeling
- Non-alcoholic fatty liver disease in patients with morbid obesity: the gut microbiota axis as a potential pathophysiology mechanism
- Increasing the efficiency of hypolipidemic therapy with the combined use of quercetin in patients with non-alcoholic fatty liver disease on the background of the metabolic syndrome
- Comparison of all-cause mortality associated with non-alcoholic fatty liver disease and metabolic dysfunction-associated fatty liver disease
- Utilizing fully-automated 3D organ segmentation for hepatic steatosis assessment with CT attenuation-based parameters
- Utilizing fully-automated 3D organ segmentation for hepatic steatosis assessment with CT attenuation-based parameters
- Mid-term Effects of Bariatric Surgery on Metabolic Dysfunction-Associated Fatty Liver Disease Remission and Predictive Factors: A Prospective Study with a Focus on Non-invasive Diagnosis
- Comparison of size of the liver between patients with non-alcoholic fatty liver disease and healthy controls
- Quantitative studies on B-mode ultrasound and point shear wave elastography of kidneys in nonazotemic dogs
- Occult liver disease: a multinational perspective
- Independent and joint association of physical activity and adequate weekday sleep duration with metabolic dysfunction-associated steatotic liver disease
- Insulin Resistance, Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Clinical and Experimental Perspective
- From Liver to Brain: How MAFLD/MASLD Impacts Cognitive Function
- Head-to-toe bedside ultrasound for adult patients on extracorporeal membrane oxygenation
- Simulation-based education in ultrasound - diagnostic and interventional abdominal focus
- ALT Poorly Predicts Nonalcoholic Fatty Liver Disease (NAFLD) and Liver Fibrosis as Determined by Vibration-Controlled Transient Elastography in Adult National Health and Nutrition Examination Survey 2017-2018: ALT Poorly Predicts NAFLD and…
- Energy Metabolism in Residents in the Low- and Moderate Altitude Regions of Central Asia with MAFLD and Type 2 Diabetes Mellitus
- Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease
- Value of constructing a non-invasive diagnostic model based on serum heme oxygenase-1 and glucose regulatory protein 78 for non-alcoholic fatty liver disease
- The role of Sirtuin 2 in liver - An extensive and complex biological process
- Inflammatory liver diseases and susceptibility to sepsis
- Thyroid function, adipokines and mitokines in metabolic dysfunction-associated steatohepatitis: A multi-centre biopsy-based observational study
- The Global Epidemic of Metabolic Fatty Liver Disease
- Review and expert opinion on MAFLD, oxidative stress and multifunctional management
- Exploring the Potential of Artificial Intelligence in Breast Ultrasound
- Determinants of non-alcoholic fatty liver disease in young people: Maternal, neonatal, and adolescent factors
- Ultrasound-guided robotic surgical procedures: a systematic review
- Diabetes Mellitus among Patients with Non-alcoholic Fatty Liver Disease Visiting the Outpatient Department of Internal Medicine in a Tertiary Care Centre
- Metabolic study of iron deposition based on magnetic resonance in patients with nonalcoholic fatty liver disease
- Healthy Lifestyle and the Risk of Metabolic Dysfunction-Associated Fatty Liver Disease: A Large Prospective Cohort Study
- Fatty liver index is an independent risk factor for all-cause mortality and major cardiovascular events in type 1 diabetes: an 11-year observational study
- Fatty liver index is an independent risk factor for all-cause mortality and major cardiovascular events in type 1 diabetes: an 11-year observational study
- Interactions between the metabolic syndrome and alcohol consumption increases the risk of liver disease
- Comparison of NAFLD, MAFLD and MASLD characteristics and mortality outcomes in United States adults
- Adipose-derived extracellular vesicles - a novel cross-talk mechanism in insulin resistance, non-alcoholic fatty liver disease, and polycystic ovary syndrome
- The relationship between advanced liver fibrosis and osteoporosis in type 2 diabetes patients with MAFLD
- Distinct changes in serum metabolites and lipid species in the onset and progression of NAFLD in Obese Chinese
- Various types of fasting diet and possible benefits in nonalcoholic fatty liver: Mechanism of actions and literature update
- Portal hypertension in patients with nonalcoholic fatty liver disease: Current knowledge and challenges
- The association between diverse serum folate with MAFLD and liver fibrosis based on NHANES 2017-2020
- Mortality in metabolic dysfunction-associated steatotic liver disease: A nationwide population-based cohort study
Evidence Blueprint
The Diagnostic Value of Ultrasound-guided Attenuation Parameter (UGAP) in metabolic fatty liver disease
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
The Diagnostic Value of Ultrasound-guided Attenuation Parameter (UGAP) in metabolic fatty liver disease
🌐 365 Days
VR Related Evidence Matrix
- First-in-human diagnostic study of hepatic steatosis with computed ultrasound tomography in echo mode
- Application of noninvasive test (acoustic attenuation imaging and ultrasonic shear wave elastography) to grade nonalcoholic fatty liver disease: An observational study
- Impact of metabolic factors on risk of cardiovascular disease in nondiabetic metabolic dysfunction-associated fatty liver disease
- Correlation of Grades of Non-alcoholic Fatty Liver on Ultrasound With Blood Parameters
- Accuracy of ultrasonographic fatty liver index using point-of-care ultrasound in stratifying non-alcoholic fatty liver disease patients
- Prospective study comparing hepatic steatosis assessment by magnetic resonance imaging and four ultrasound methods in 105 successive patients
- Ultrasound Shear Wave Attenuation Imaging for Grading Liver Steatosis in Volunteers and Patients With Non-alcoholic Fatty Liver Disease: A Pilot Study
- Nonalcoholic Fatty Liver Disease and Continuous Metabolic Syndrome in Adolescents with Overweight/Obesity
- Diagnostic Performance of Quantitative Ultrasound Parameters in Non-alcoholic Fatty Liver Disease
- Prevalence, risk factors and diagnostic accuracy of non-invasive tests for NAFLD in people with type 1 diabetes
- Detection of Moderate Hepatic Steatosis on Portal Venous Phase Contrast-Enhanced CT: Evaluation Using an Automated Artificial Intelligence Tool
- MAFLD might be better in identifying subjects with sarcopenia or cardiovascular risk than NAFLD: A nationwide study
- Increased Risk of Colorectal Adenomas with Metabolic-Associated Fatty Liver Disease Components
- Analysis of clinical features and identification of risk factors in patients with non-alcoholic fatty liver disease based on FibroTouch
- Ultrasound LI-RADS Visualization Scores on Surveillance Ultrasound for Hepatocellular Carcinoma: A Systematic Review With Meta-analysis
- Impact renaming non-alcoholic fatty liver disease to metabolic associated fatty liver disease in prevalence, characteristics and risk factors
- Toward acquisition protocol standardization for estimating liver fat content using ultrasound attenuation coefficient imaging
- Correlation between neck circumference and hepatic steatosis determined by controlled attenuation parameter
- High prevalence of de novo metabolic dysfunction-associated fatty liver disease after liver transplantation and the role of controlled attenuation parameter
- Reproducibility and accuracy of a pocket-size ultrasound device in assessing liver steatosis
- Ultrasonographic findings of metabolic dysfunction-associated fatty liver disease: A comparative study with non-alcoholic fatty liver disease and clinical characteristics
- Metabolic dysfunction: The silenced connection with fatty liver disease
- Usefulness of controlled attenuation parameter in monitoring clinically relevant decline of hepatic steatosis for non-alcoholic fatty liver disease
- Bronchiectasis Severity Index and FACED scores in patients with allergic bronchopulmonary aspergillosis complicating asthma: do they correlate with immunological severity or high-attenuation mucus?
- Breaking new ground: MASLD vs. MAFLD-which holds the key for risk stratification?
- Feasibility and Safety of Percutaneous Puncture Guided by a 5G-Based Telerobotic Ultrasound System: An Experimental Study
- Research progress of celastrol on the prevention and treatment of metabolic associated fatty liver disease
- Liver and atherosclerotic risks of patients with cryptogenic steatotic liver disease
- Diagnostic Value of FibroTouch in Identifying Hepatic Steatosis in NAFLD with MRI-PDFF as the Reference Standard
- DNA methylation age acceleration contributes to the development and prediction of non-alcoholic fatty liver disease
- Diagnostic Performance of Biomarker-Based Scores as Predictors of Metabolic Dysfunction-Associated Fatty Liver Disease Risk in Healthy Children
- Effect of the nomenclature of non-alcoholic fatty liver disease on diagnosis and treatment of fatty liver disease concomitant with other liver diseases
- Performance of ATT and UDFF in the diagnosis of non-alcoholic fatty liver: An animal experiment
- Metabolic Dysfunction-associated fatty liver disease and incident heart failure risk: the Kailuan cohort study
- Ultrasonic Sound Speed Estimation for Liver Fat Quantification: A Review by the AIUM-RSNA QIBA Pulse-Echo Quantitative Ultrasound Initiative
- Metabolic-associated fatty liver disease: a selective review of pathogenesis, diagnostic approaches, and therapeutic strategies
- Correlation of the Pediatric Metabolic Index with NAFLD or MAFLD diagnosis, and serum adipokine levels in children
- Targeting metabolic-associated fatty liver disease in diabetic kidney disease: A call to action
- Non-Alcoholic Fatty Liver Disease and Liver Fibrosis in Persons with Type 2 Diabetes Mellitus in Ghana: A Study of Prevalence, Severity, and Contributing Factors Using Transient Elastography
- The outcomes of nutritional therapy in patients with non-alcoholic fatty liver disease (NAFLD): Pitfalls in getting fit from fat
- Role of Anthropometric Indices in the Prediction of Non-alcoholic Fatty Liver Disease in a Rural Population of Bangladesh
- Waist Circumference as a Risk Factor for Non-Alcoholic Fatty Liver Disease in Older Adults in Guayaquil, Ecuador
- Metabolic dysfunction-associated fatty liver disease in people living with HIV
- Quantitative ultrasound fatty liver evaluation in a pediatric population: comparison with magnetic resonance imaging of liver proton density fat fraction
- Influence of Gut Microbiota and Its Metabolites on Progression of Metabolism-Associated Fatty Liver Disease
- Visceral and subcutaneous abdominal fat is associated with non-alcoholic fatty liver disease while augmenting Metabolic Syndrome's effect on non-alcoholic fatty liver disease: A cross-sectional study of NHANES 2017-2018
- Prevalence and clinical outcomes in subtypes of metabolic associated fatty liver disease
- Fatty liver disease's renaming impacts on drug clinical trials
- Genetic association study identifies genetic variants for non-alcoholic fatty liver without comorbidities in the Korean population
- Association between hypertension and the prevalence of liver steatosis and fibrosis
- The Prothrombotic Tendency of Metabolic-Associated Fatty Liver Disease
- Triglyceride glucose-waist circumference: the optimum index to screen nonalcoholic fatty liver disease in non-obese adults
- Critical appraisal of metabolic dysfunction-associated steatotic liver disease: Implication of Janus-faced modernity
- Endohepatology: The endoscopic armamentarium in the hand of the hepatologist
- Metabolic Derangement in Non-Alcoholic Fatty Liver Disease: Opportunities for Early Diagnostic and Prognostic Markers
- Mass spectrometry imaging-based metabolomics highlights spatial metabolic alterations in three types of liver injuries
- Prevalence and Prognostic Value of Non-Alcoholic Fatty Liver Disease in Patients Hospitalized With Decompensated Chronic Heart Failure
- Muscle strength and non-alcoholic fatty liver disease/metabolic-associated fatty liver disease
- From metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease: Controversy and consensus
- The utility and tolerability of ultrasound guided muscle biopsy in the investigation of myopathy: a follow-up study
- Prevalence of non-alcoholic fatty liver disease and liver fibrosis in a general population cohort from Argentina
- Association between cardiometabolic index and controlled attenuation parameter in U.S. adults with NAFLD: findings from NHANES (2017-2020)
- Effect of a moderately carbohydrate-restricted diet on liver enzymes, steatosis and fibrosis in normal-weight individuals with non-alcoholic fatty liver disease: study protocol for a parallel randomised controlled clinical trial
- Effect of Intermittent Fasting on Lipid Profile, Anthropometric and Hepatic Markers in Non-Alcoholic Fatty Liver Disease (NAFLD): A Systematic Review